SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020170
Filing Date
2021-08-16
Accepted
2021-08-16 16:16:36
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1662083
2 ex3-8.htm EX-3.8 119206
3 ex10-1.htm EX-10.1 48783
4 ex10-2.htm EX-10.2 10286
5 ex31-1.htm EX-31.1 12904
6 ex31-2.htm EX-31.2 12925
7 ex32-1.htm EX-32.1 9874
8 image_001.jpg GRAPHIC 2946
  Complete submission text file 0001493152-21-020170.txt   7676904

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE qlgn-20210630.xsd EX-101.SCH 61100
10 XBRL CALCULATION FILE qlgn-20210630_cal.xml EX-101.CAL 60530
11 XBRL DEFINITION FILE qlgn-20210630_def.xml EX-101.DEF 248886
12 XBRL LABEL FILE qlgn-20210630_lab.xml EX-101.LAB 452602
13 XBRL PRESENTATION FILE qlgn-20210630_pre.xml EX-101.PRE 358564
14 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1328134
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 211178429
SIC: 2834 Pharmaceutical Preparations